Trademark: 90760694
Status Date
Monday, January 1, 2024
Filing Date
Tuesday, June 8, 2021
Published for Opposition
Tuesday, October 4, 2022
Abandoned Date
Monday, January 1, 2024
5 pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of central nervous system disorders, multiple sclerosis, autoimmune diseases and B-cell mediated non-oncological diseases
The wording RYUMSI has no meaning in a foreign language.
Jan 2, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 1, 2024
Abandonment - No Use Statement Filed
May 12, 2023
Notice Of Approval Of Extension Request E-Mailed
May 10, 2023
Sou Extension 1 Granted
May 10, 2023
Sou Extension 1 Filed
May 10, 2023
Sou Teas Extension Received
Nov 29, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2022
Published For Opposition
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Aug 26, 2022
Approved For Pub - Principal Register
Aug 13, 2022
Teas/Email Correspondence Entered
Aug 12, 2022
Correspondence Received In Law Office
Aug 12, 2022
Teas Response To Office Action Received
Feb 25, 2022
Notification Of Non-Final Action E-Mailed
Feb 25, 2022
Non-Final Action E-Mailed
Feb 25, 2022
Non-Final Action Written
Feb 25, 2022
Assigned To Examiner
Aug 28, 2021
New Application Office Supplied Data Entered
Jun 11, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
